Exchanges & Data · NYSE: EFX
Equifax earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 3 Feb 2027
Latest: Q3 2026
Equifax's new-product Vitality Index hit a record over 17% as EFX.AI and proprietary data offset a sharply weaker U.S. mortgage market in the second half.
Equifax's growth this quarter came from new products and non-mortgage markets. Diversified Markets grew in every business unit, led by Talent Solutions (over 20% growth), Consumer Lending and Financial Institutions. Management says new products built on the EFX Cloud, EFX.AI and proprietary data made up a record over 17% of growth, well above its 10% long-term goal. In mortgage, the company is pushing VantageScore, now used by about 2,000 lenders.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $1.4B * |
| Q1 2025 | $1.4B |
| Q2 2025 | $1.5B |
| Q3 2025 | $1.5B |
| Q4 2025 | $1.6B * |
| Q1 2026 | $1.6B |
| Q2 2026 | $1.7B |
| Q3 2026 | $1.7B |
Data
| Q1 2025 | $1.06 |
| Q2 2025 | $1.53 |
| Q3 2025 | $1.29 |
| Q1 2026 | $1.42 |
| Q2 2026 | $1.54 |
| Q3 2026 | $1.79 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | 20.3% |
| Q1 2025 | 16.4% |
| Q2 2025 | 20.2% |
| Q3 2025 | 17.1% |
| Q4 2025 | 18.3% |
| Q1 2026 | 17.4% |
| Q2 2026 | 18.5% |
| Q3 2026 | 21.0% |
Data
| Q4 2024 | $205.9M |
| Q1 2025 | $116.7M |
| Q2 2025 | $238.9M |
| Q3 2025 | $437.9M |
| Q4 2025 | $340.8M |
| Q1 2026 | $121.5M |
| Q2 2026 | $204.8M |
| Q3 2026 | $436.9M |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4Bd | $1.4B | $1.5B | $1.5B | $1.6Bd | $1.6B | $1.7B | $1.7B |
| Operating income | $288.1Md | $235.8M | $310.8M | $264.3M | $284.2Md | $287.7M | $314.2M | $355.3M |
| Operating margin | 20.3% | 16.4% | 20.2% | 17.1% | 18.3% | 17.4% | 18.5% | 21.0% |
| Net income | $174.0Md | $133.1M | $191.3M | $160.2M | $175.8Md | $171.5M | $183.9M | $211.7M |
| Diluted EPS | — | $1.06 | $1.53 | $1.29 | — | $1.42 | $1.54 | $1.79 |
| Operating cash flow | $324.8Md | $223.9M | $361.1Md | $559.9Md | $470.8Md | $241.9M | $339.8Md | $560.4Md |
| Capital expenditure | $118.9Md | $107.2M | $122.2Md | $122.0Md | $130.0Md | $120.4M | $135.0Md | $123.5Md |
| Free cash flow | $205.9M | $116.7M | $238.9M | $437.9M | $340.8M | $121.5M | $204.8M | $436.9M |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-K and 10-Q filings
- 20 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 21 Jul 202610-Q for the period ended 30 Jun 2026SEC ↗
- 21 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 19 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 21 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 22 Jul 202510-Q for the period ended 30 Jun 2025SEC ↗
- 22 Apr 202510-Q for the period ended 31 Mar 2025SEC ↗
- 20 Feb 202510-K for the period ended 31 Dec 2024SEC ↗